Literature DB >> 32168526

MicroRNAs and Adrenocortical Tumors: Where do we Stand on Primary Aldosteronism?

Zsófia Tömböl1, Péter István Turai1, Ábel Decmann1, Peter Igaz1,2.   

Abstract

MicroRNAs, the endogenous mediators of RNA interference, interact with the renin-angiotensin-aldosterone system, regulate aldosterone secretion and aldosterone effects. Some novel data show that the expression of some microRNAs is altered in primary aldosteronism, and some of these appear to have pathogenic relevance, as well. Differences in the circulating microRNA expression profiles between the two major forms of primary aldosteronism, unilateral aldosterone-producing adenoma and bilateral adrenal hyperplasia have also been shown. Here, we present a brief synopsis of these findings focusing on the potential relevance of microRNA in primary aldosteronism. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32168526     DOI: 10.1055/a-1116-2366

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  4 in total

1.  Adrenal Venous Sampling for Subtype Diagnosis of Primary Hyperaldosteronism.

Authors:  Mitsuhide Naruse; Akiyo Tanabe; Koichi Yamamoto; Hiromi Rakugi; Mitsuhiro Kometani; Takashi Yoneda; Hiroki Kobayashi; Masanori Abe; Youichi Ohno; Nobuya Inagaki; Shoichiro Izawa; Masakatsu Sone
Journal:  Endocrinol Metab (Seoul)       Date:  2021-10-21

Review 2.  Primary aldosteronism: Pathophysiological mechanisms of cell death and proliferation.

Authors:  Martina Tetti; Siyuan Gong; Franco Veglio; Martin Reincke; Tracy Ann Williams
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-08       Impact factor: 6.055

Review 3.  MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma.

Authors:  Mario Detomas; Claudia Pivonello; Bianca Pellegrini; Laura-Sophie Landwehr; Silviu Sbiera; Rosario Pivonello; Cristina L Ronchi; Annamaria Colao; Barbara Altieri; Maria Cristina De Martino
Journal:  Cells       Date:  2022-07-18       Impact factor: 7.666

4.  Progress in Primary Aldosteronism 2019: New Players on the Block?

Authors:  Martin Reincke; Felix Beuschlein; Tracy Ann Williams
Journal:  Horm Metab Res       Date:  2020-06-16       Impact factor: 2.936

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.